Efficacy and Safety of Vedolizumab for Inflammatory Bowel Disease in Clinical Practice

被引：1
|
作者：
Chaudrey, Khadija [1 ]
Lightner, Amy [1 ]
Singh, Siddharth [2 ]
Faubion, William [3 ]
Tremaine, William [3 ]
Bruining, David [3 ]
Papadakis, Konstantinos [3 ]
Kisiel, John [3 ]
CoelhoPrabhu, Nayantara [3 ]
Raffals, Laura [3 ]
Kane, Sunanda [3 ]
Loftus, Edward, Jr. [3 ]
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] UCSD Med Ctr, San Diego, CA USA
[3] Mayo Clin, Rochester, MN USA
来源：
INFLAMMATORY BOWEL DISEASES | 2016年 / 22卷
关键词：
D O I：
10.1097/01.MIB.0000480124.51296.b7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-033
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [41] Vedolizumab (Entyvio) for Inflammatory Bowel Disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1451): : 86 - 88
  • [42] Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials
    Feagan, Brian G.
    Bhayat, Fatima
    Khalid, Mona
    Blake, Aimee
    Travis, Simon P. L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (08): : 905 - 919
  • [43] Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice
    Ylisaukko-oja, Tero
    Torvinen, Saku
    Aaltonen, Jaakko
    Nuutinen, Heikki
    Blomster, Timo
    Jussila, Airi
    Pajala, Markku
    Salminen, Kimmo
    Moilanen, Veikko
    Hakala, Kalle
    Kellokumpu, Mikko
    Toljamo, Kari
    Rautiainen, Henna
    Kuisma, Juha
    Peraaho, Markku
    Molander, Pauliina
    Silvennoinen, Jouni
    Liukkonen, Ville
    Henricson, Hans
    Tillonen, Jyrki
    Esterinen, Mirva
    Nielsen, Christian
    Hirsi, Eija
    Laane, Margus
    Suhonen, Ulla-Maija
    Vihriala, Ilkka
    Makela, Petri
    Puhto, Mika
    Punkkinen, Jari
    Sulonen, Hannu
    Herrala, Sauli
    Jokelainen, Jari
    Tamminen, Klaus
    Sipponen, Taina
    [J]. BIOLOGICALS, 2019, 58 : 50 - 56
  • [44] Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study
    Baumgart, D. C.
    Bokemeyer, B.
    Drabik, A.
    Stallmach, A.
    Schreiber, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (10) : 1090 - 1102
  • [45] GRANULOCYTOAPHERESIS IN INFLAMMATORY BOWEL DISEASE: SAFETY AND EFFICACY
    Martin, Dominguez F.
    Mingot, Castellano M. E.
    Leo, E.
    Escamilla, Gomez, V
    Calderon, Cabrera C.
    Perez-Simon, J. A.
    [J]. HAEMATOLOGICA, 2020, 105 : 250 - 251
  • [46] Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice
    Stein, Juergen
    Walper, Andreas
    Klemm, Wolfgang
    Farrag, Karima
    Aksan, Ayseguel
    Dignass, Axel
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1059 - 1065
  • [47] Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience
    Kopylov, Uri
    Ron, Yulia
    Avni-Biron, Irit
    Koslowsky, Benjamin
    Waterman, Matti
    Daher, Saleh
    Ungar, Bella
    Yanai, Henit
    Maharshak, Nitsan
    Ben-Bassat, Ofer
    Lichtenstein, Lev
    Shitrit, Ariella Bar-Gil
    Israeli, Eran
    Schwartz, Doron
    Zittan, Eran
    Eliakim, Rami
    Chowers, Yehuda
    Ben-Horin, Shomron
    Dotan, Iris
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (03) : 404 - 408
  • [48] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
  • [49] Vedolizumab Trough Levels in Inflammatory Bowel Disease: Initial Clinical Experience
    Badr, Al-Bawardy
    Guilherme, Piovezani Ramos
    Loftus, Edward, Jr.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S26 - S26
  • [50] Clinical utility of vedolizumab trough levels in the management of inflammatory bowel disease
    Maillard, Michel H.
    Jelk, Daniele
    Perreau, Matthieu
    Rossel, Jean-Benoit
    Pittet, Valerie
    Michetti, Pierre
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 6S - 6S
12345